Literature DB >> 19345130

SCN5A mutation associated with acute myocardial infarction.

Antonio Oliva1, Dan Hu, Sami Viskin, Tabitha Carrier, Jonathan M Cordeiro, Hector Barajas-Martinez, Yusheng Wu, Elena Burashnikov, Ramon Brugada, Rafael Rosso, Alexandra Guerchicoff, Guido Pollevick, Vincenzo L Pascali, Charlie Antzelevitch.   

Abstract

Ventricular tachycardia and fibrillation (VT/VF) complicating Brugada syndrome, a genetic disorder linked to SCN5A mutations, and VF complicating acute myocardial infarction (AMI) have both been linked to phase 2 reentry. Because of these mechanistic similarities in arrhythmogenesis, we examined the contribution of SCN5A mutations to VT/VF complicating AMI. Nineteen consecutive patients developing VF during AMI were enrolled. Wild-type (WT) and mutant SCN5A genes were co-expressed with SCN1B in TSA201 cells and studied using whole-cell patch-clamp techniques. One missense mutation (G400A) in SCN5A was detected in a conserved region among the cohort of 19 patients. A H558R polymorphism was detected on the same allele. Unlike the other 18 patients who each developed 1-2 VF episodes during acute MI, the mutation carrier developed six episodes of VT/VF within the first 12 hours. All VT/VF episodes were associated with ST segment changes and were initiated by short-coupled extrasystoles. We describe the first sodium channel mutation to be associated with the development of an arrhythmic storm during acute ischemia. These findings suggest that a loss of function in SCN5A may predispose to ischemia induced arrhythmic storm. These results could be very useful for forensic implications regarding genetic screening in relatives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345130      PMCID: PMC2813686          DOI: 10.1016/j.legalmed.2009.02.044

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  8 in total

1.  Cellular basis for ST-segment changes observed during ischemia.

Authors:  José M Di Diego; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

2.  Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia.

Authors:  A Lukas; C Antzelevitch
Journal:  Cardiovasc Res       Date:  1996-09       Impact factor: 10.787

Review 3.  Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

4.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

Review 5.  Genetics of acquired long QT syndrome.

Authors:  Dan M Roden; Prakash C Viswanathan
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

6.  ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.

Authors:  Takashi Noda; Wataru Shimizu; Atsushi Taguchi; Kazuhiro Satomi; Kazuhiro Suyama; Takashi Kurita; Naohiko Aihara; Shiro Kamakura
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

Review 7.  Human genomics and its impact on arrhythmias.

Authors:  Dan M Roden
Journal:  Trends Cardiovasc Med       Date:  2004-04       Impact factor: 6.677

8.  Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia.

Authors:  Gan-Xin Yan; Ajay Joshi; Donglin Guo; Thinn Hlaing; Jack Martin; Xiaoping Xu; Peter R Kowey
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

  8 in total
  6 in total

1.  Case report: Synergetic effect of ischaemia and increased vagal tone inducing ventricular fibrillation in a patient with Brugada syndrome.

Authors:  Sophie C H Van Malderen; Carl J Schultz; Luc Jordaens
Journal:  Eur Heart J Case Rep       Date:  2020-07-30

Review 2.  Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction.

Authors:  Charlotte Glinge; Stefan Sattler; Reza Jabbari; Jacob Tfelt-Hansen
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

3.  Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification.

Authors:  Michelle M Monasky; Emanuele Micaglio; Emanuela T Locati; Carlo Pappone
Journal:  Front Cardiovasc Med       Date:  2021-04-21

4.  Human Plasma Metabolomics Identify 9-cis-retinoic Acid and Dehydrophytosphingosine Levels as Novel biomarkers for Early Ventricular Fibrillation after ST-elevated Myocardial Infarction.

Authors:  Jieying Luo; Junaid Ahmed Shaikh; Lei Huang; Lei Zhang; Shahid Iqbal; Yu Wang; Bojiang Liu; Quan Zhou; Aisha Ajmal; Maryam Rizvi; Maryam Ajmal; Yingwu Liu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 5.  Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death.

Authors:  Benoît Jagu; Flavien Charpentier; Gilles Toumaniantz
Journal:  Front Physiol       Date:  2013-09-20       Impact factor: 4.566

6.  Overlap Arrhythmia Syndromes Resulting from Multiple Genetic Variations Studied in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Jacqueline A Treat; Ryan Pfeiffer; Hector Barajas-Martinez; Robert J Goodrow; Corina Bot; Rodolfo J Haedo; Ronald Knox; Jonathan M Cordeiro
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.